Pittenger & Anderson Inc’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.08M Buy
50,530
+25
+0% +$2.89K 0.24% 92
2025
Q4
$5.32M Buy
50,505
+950
+2% +$89.2K 0.2% 103
2025
Q3
$4.16M Buy
49,555
+190
+0.4% +$15.6K 0.15% 122
2025
Q2
$3.91M Buy
49,365
+1,125
+2% +$89.4K 0.14% 121
2025
Q1
$4.33M Buy
48,240
+875
+2% +$81.7K 0.16% 114
2024
Q4
$4.71M Sell
47,365
-22
-0% -$2.27K 0.17% 106
2024
Q3
$5.38M Buy
47,387
+425
+0.9% +$50.5K 0.2% 95
2024
Q2
$5.81M Buy
46,962
+205
+0.4% +$26.4K 0.24% 91
2024
Q1
$6.17M Hold
46,757
0.25% 89
2023
Q4
$5.1M Buy
46,757
+132
+0.3% +$13.7K 0.23% 93
2023
Q3
$4.8M Sell
46,625
-2,345
-5% -$253K 0.24% 93
2023
Q2
$5.65M Buy
48,970
+885
+2% +$100K 0.27% 91
2023
Q1
$5.12M Buy
48,085
+65
+0.1% +$7.02K 0.26% 94
2022
Q4
$5.33M Buy
48,020
+970
+2% +$99.2K 0.29% 93
2022
Q3
$4.05M Buy
47,050
+705
+2% +$62.9K 0.24% 100
2022
Q2
$4.22M Buy
46,345
+340
+0.7% +$30.1K 0.25% 98
2022
Q1
$3.77M Buy
46,005
+960
+2% +$75.7K 0.19% 113
2021
Q4
$3.45M Buy
45,045
+2,445
+6% +$195K 0.16% 121
2021
Q3
$3.2M Buy
42,600
+650
+2% +$49.4K 0.16% 119
2021
Q2
$3.26M Sell
41,950
-12
-0% -$893 0.17% 121
2021
Q1
$3.09M Buy
41,962
+299
+0.7% +$22.1K 0.17% 113
2020
Q4
$3.25M Sell
41,663
-2,028
-5% -$155K 0.18% 115
2020
Q3
$3.46M Buy
43,691
+2,049
+5% +$160K 0.22% 102
2020
Q2
$3.07M Buy
41,642
+277
+0.7% +$20.9K 0.22% 102
2020
Q1
$3.04M Sell
41,365
-24
-0.1% -$1.89K 0.26% 94
2019
Q4
$3.59M Buy
41,389
+330
+0.8% +$27.1K 0.24% 104
2019
Q3
$3.3M Buy
41,059
+3,266
+9% +$262K 0.24% 106
2019
Q2
$3.02M Buy
37,793
+529
+1% +$40.5K 0.23% 115
2019
Q1
$2.96M Buy
37,264
+530
+1% +$39.6K 0.23% 110
2018
Q4
$2.68M Buy
36,734
+1,097
+3% +$77.4K 0.25% 103
2018
Q3
$2.41M Buy
35,637
+1,132
+3% +$72.1K 0.19% 126
2018
Q2
$2M Hold
34,505
0.17% 133
2018
Q1
$1.79M Sell
34,505
-6,398
-16% -$346K 0.16% 140
2017
Q4
$2.2M Buy
40,903
+2,447
+6% +$136K 0.19% 126
2017
Q3
$2.35M Buy
38,456
+712
+2% +$43.2K 0.21% 111
2017
Q2
$2.31M Sell
37,744
-131
-0.3% -$7.97K 0.22% 113
2017
Q1
$2.3M Sell
37,875
-644
-2% -$39.1K 0.23% 115
2016
Q4
$2.16M Buy
38,519
+1,624
+4% +$95K 0.23% 110
2016
Q3
$2.2M Buy
36,895
+451
+1% +$26.4K 0.24% 106
2016
Q2
$2M Buy
36,444
+8,227
+29% +$438K 0.22% 117
2016
Q1
$1.43M Buy
28,217
+717
+3% +$35.1K 0.17% 139
2015
Q4
$1.39M Buy
27,500
+959
+4% +$48.4K 0.17% 139
2015
Q3
$1.25M Hold
26,541
0.17% 142
2015
Q2
$1.44M Buy
26,541
+666
+3% +$37.4K 0.19% 135
2015
Q1
$1.42M Buy
25,875
+5,250
+25% +$297K 0.18% 134
2014
Q4
$1.12M Buy
20,625
+231
+1% +$12.9K 0.15% 144
2014
Q3
$1.15M Buy
20,394
+367
+2% +$20.6K 0.17% 123
2014
Q2
$1.11M Hold
20,027
0.16% 127
2014
Q1
$1.08M Buy
20,027
+2,237
+13% +$116K 0.15% 146
2013
Q4
$850K Buy
17,790
+136
+0.8% +$6.22K 0.12% 163
2013
Q3
$802K Buy
17,654
+2,610
+17% +$119K 0.13% 156
2013
Q2
$667K Buy
+15,044
New +$672K 0.12% 159

Other funds holding MRK

Pittenger & Anderson Inc's MRK Position: Q1 2026 in Review

Pittenger & Anderson Inc increased its Merck (MRK) stake by 0.05% in Q1 2026, buying an estimated $2.89K and bringing the position to 50,530 shares worth $6.08M. The position accounts for 0.24% of the portfolio, ranked #92.

Pittenger & Anderson Inc first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.17M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Pittenger & Anderson Inc held 50,530 shares of Merck worth $6.08M as of Q1 2026.
  • Pittenger & Anderson Inc bought 25 Merck shares in Q1 2026, an estimated $2.89K.
  • Merck made up 0.24% of Pittenger & Anderson Inc's portfolio in Q1 2026, its #92 holding.
  • Pittenger & Anderson Inc first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Pittenger & Anderson Inc's Merck position peaked at $6.17M in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Pittenger & Anderson Inc's 13F filing for Q1 2026, filed 1 May 2026.